Follow
William Blanco-Bose
William Blanco-Bose
EPFL, ISREC, Stanford, Amazentis
Verified email at amazentis.com
Title
Cited by
Cited by
Year
Hematopoietic stem cells reversibly switch from dormancy to self-renewal during homeostasis and repair
A Wilson, E Laurenti, G Oser, RC van der Wath, W Blanco-Bose, ...
Cell 135 (6), 1118-1129, 2008
21952008
IFNα activates dormant haematopoietic stem cells in vivo
MAG Essers, S Offner, WE Blanco-Bose, Z Waibler, U Kalinke, ...
Nature 458 (7240), 904-908, 2009
14722009
VEGF gene delivery to myocardium: deleterious effects of unregulated expression
RJ Lee, ML Springer, WE Blanco-Bose, R Shaw, PC Ursell, HM Blau
Circulation 102 (8), 898-901, 2000
9092000
Lentiviral-mediated RNA interference
T Abbas-Terki, W Blanco-Bose, N Déglon, W Pralong, P Aebischer
Human gene therapy 13 (18), 2197-2201, 2002
4542002
Hematopoietic stem cell function and survival depend on c-Myc and N-Myc activity
E Laurenti, B Varnum-Finney, A Wilson, I Ferrero, WE Blanco-Bose, ...
Cell stem cell 3 (6), 611-624, 2008
3502008
The mitophagy activator urolithin A is safe and induces a molecular signature of improved mitochondrial and cellular health in humans
PA Andreux, W Blanco-Bose, D Ryu, F Burdet, M Ibberson, P Aebischer, ...
Nature Metabolism 1 (6), 595-603, 2019
3492019
Dormant and self‐renewing hematopoietic stem cells and their niches
A Wilson, GM Oser, M Jaworski, WE BLANCO‐BOSE, E Laurenti, ...
Annals of the New York Academy of Sciences 1106 (1), 64-75, 2007
3232007
Purification of mouse primary myoblasts based on α7 integrin expression
WE Blanco-Bose, CC Yao, RH Kramer, HM Blau
Experimental cell research 265 (2), 212-220, 2001
2012001
C‐Myc and its target FoxM1 are critical downstream effectors of constitutive androstane receptor (CAR) mediated direct liver hyperplasia
WE Blanco‐Bose, MJ Murphy, A Ehninger, S Offner, C Dubey, W Huang, ...
Hepatology 48 (4), 1302-1311, 2008
1532008
Safety assessment of Urolithin A, a metabolite produced by the human gut microbiota upon dietary intake of plant derived ellagitannins and ellagic acid
J Heilman, P Andreux, N Tran, C Rinsch, W Blanco-Bose
Food and Chemical Toxicology 108, 289-297, 2017
1092017
Urolithin A improves muscle strength, exercise performance, and biomarkers of mitochondrial health in a randomized trial in middle-aged adults
A Singh, D D’Amico, PA Andreux, AM Fouassier, W Blanco-Bose, ...
Cell Reports Medicine 3 (5), 2022
822022
Direct supplementation with Urolithin A overcomes limitations of dietary exposure and gut microbiome variability in healthy adults to achieve consistent levels across the …
A Singh, D D’Amico, PA Andreux, G Dunngalvin, T Kern, W Blanco-Bose, ...
European journal of clinical nutrition 76 (2), 297-308, 2022
562022
Pten loss in the bone marrow leads to G-CSF–mediated HSC mobilization
M Tesio, GM Oser, I Baccelli, W Blanco-Bose, H Wu, JR Göthert, ...
Journal of Experimental Medicine 210 (11), 2337-2349, 2013
502013
Compositions and methods for improving mitochondrial function and treating neurodegenerative diseases and cognitive disorders
CL Rinsch, W Blanco-Bose, B Schneider, C Thomas, C Sandi, J Auwerx, ...
US Patent 9,872,850, 2018
242018
Compositions and methods for improving mitochondrial function and treating neurodegenerative diseases and cognitive disorders
CL Rinsch, W Blanco-Bose, B Schneider, C Thomas, C Sandi, J Auwerx, ...
US Patent 9,872,850, 2018
242018
Laminin-induced change in conformation of preexisting α7β1 integrin signals secondary myofiber formation
WE Blanco-Bose, HM Blau
Developmental Biology 233 (1), 148-160, 2001
232001
Enhancing autophagy or increasing longevity by administration of urolithins or precursors thereof
CL Rinsch, W Blanco-Bose, B Schneider, L Mouchiroud, D Ryu, ...
US Patent 11,020,373, 2021
192021
Orally administered urolithin A is safe and modulates muscle and mitochondrial biomarkers in elderly
A Singh, P Andreux, W Blanco-Bose, D Ryu, P Aebischer, J Auwerx, ...
Innovation in Aging 1 (suppl_1), 1223-1224, 2017
182017
Inducing tolerance to a soluble foreign antigen by encapsulated cell transplants
WE Blanco-Bose, BL Schneider, P Aebischer
Molecular Therapy 13 (2), 447-456, 2006
82006
Compositions and methods for improving mitochondrial function and treating neurodegenerative diseases and cognitive disorders
C Rinsch, W Blanco-Bose, B Schneider, C Thomas, C Sandi, J Auwerx, ...
US Patent 10,485,782, 2019
62019
The system can't perform the operation now. Try again later.
Articles 1–20